| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |